In The News: September 2010

Healthy people who take nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief may be increasing their risk of heart attack and stroke. Researchers in Denmark studied 1,028,437 healthy individuals from 1997 to 2005 for increased cardiovascular morbidity with the use of prescription drugs rofecoxib (Vioxx), diclofenac (Cambia, Cataflam, Voltaren, Zipsor), celecoxib (Celebrex), and over-the-counter (OTC) pain relievers naproxen (Aleve) and ibuprofen (Advil, Motrin, Midol, Nuprin). [Rofecoxib, no longer available in the U.S., was taken off the market in 2004.] Researchers found that those on diclofenac had a 91 percent higher risk of heart attack and stroke; patients who took the largest doses of diclofenac actually saw their risk of heart attack double.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access